Class,Axioms,Coverage
file:/Users/mostafa/Projects/forget/data/experiment3/multiple-sclerosis,2,0.0027
file:/Users/mostafa/Projects/forget/data/experiment3/quinolone-antibiotic,1,0.0014
file:/Users/mostafa/Projects/forget/data/experiment3/intravascular-large-b-cell-lymphoma,1,0.0014
file:/Users/mostafa/Projects/forget/data/experiment3/immunotherapeutic-drug,1,0.0014
file:/Users/mostafa/Projects/forget/data/experiment3/diseasespathologysymptoms--knapsack-,1,0.0014
file:/Users/mostafa/Projects/forget/data/experiment3/powerful-drug,1,0.0014
file:/Users/mostafa/Projects/forget/data/experiment3/---dexrazoxane,1,0.0014
file:/Users/mostafa/Projects/forget/data/experiment3/night-sweats,1,0.0014
file:/Users/mostafa/Projects/forget/data/experiment3/myeloblasts-under-10-percent-of-peripheral-blood-white-cells,1,0.0014
file:/Users/mostafa/Projects/forget/data/experiment3/exemestane,1,0.0014
file:/Users/mostafa/Projects/forget/data/experiment3/defined-formula-diet,1,0.0014
file:/Users/mostafa/Projects/forget/data/experiment3/mometasone-furoate-formoterol-fumarate-drug-combination,1,0.0014
file:/Users/mostafa/Projects/forget/data/experiment3/danofloxacin,3,0.0041
file:/Users/mostafa/Projects/forget/data/experiment3/flufenamic-acid,1,0.0014
file:/Users/mostafa/Projects/forget/data/experiment3/clofibrate,1,0.0014
file:/Users/mostafa/Projects/forget/data/experiment3/sciatica,1,0.0014
file:/Users/mostafa/Projects/forget/data/experiment3/gummatous-hepatitis,1,0.0014
file:/Users/mostafa/Projects/forget/data/experiment3/cellular-organism,4,0.0054
file:/Users/mostafa/Projects/forget/data/experiment3/liver-inflammation,1,0.0014
file:/Users/mostafa/Projects/forget/data/experiment3/antiphlogistic,1,0.0014
file:/Users/mostafa/Projects/forget/data/experiment3/bile-acid-sequestrant,1,0.0014
file:/Users/mostafa/Projects/forget/data/experiment3/pudendal-neuralgia,1,0.0014
file:/Users/mostafa/Projects/forget/data/experiment3/leukocytosis,1,0.0014
file:/Users/mostafa/Projects/forget/data/experiment3/cholangiolitic-hepatitis,1,0.0014
file:/Users/mostafa/Projects/forget/data/experiment3/nepal,1,0.0014
file:/Users/mostafa/Projects/forget/data/experiment3/sri-lanka,1,0.0014
file:/Users/mostafa/Projects/forget/data/experiment3/inverse-agonist,1,0.0014
file:/Users/mostafa/Projects/forget/data/experiment3/hypothyroidism,2,0.0027
file:/Users/mostafa/Projects/forget/data/experiment3/thrombocytosis,1,0.0014
file:/Users/mostafa/Projects/forget/data/experiment3/antipyretic,1,0.0014
file:/Users/mostafa/Projects/forget/data/experiment3/lymphopenia,1,0.0014
file:/Users/mostafa/Projects/forget/data/experiment3/thrombopoietin-receptor-agonists,1,0.0014
file:/Users/mostafa/Projects/forget/data/experiment3/subacute-hepatitis,1,0.0014
file:/Users/mostafa/Projects/forget/data/experiment3/singapore,1,0.0014
file:/Users/mostafa/Projects/forget/data/experiment3/counterfeit-drug,1,0.0014
file:/Users/mostafa/Projects/forget/data/experiment3/amitriptyline,1,0.0014
file:/Users/mostafa/Projects/forget/data/experiment3/anti-asthmatic-drug,1,0.0014
file:/Users/mostafa/Projects/forget/data/experiment3/bridged-compound,1,0.0014
file:/Users/mostafa/Projects/forget/data/experiment3/disorder-involving-pain,1,0.0014
file:/Users/mostafa/Projects/forget/data/experiment3/inhibitor,1,0.0014
file:/Users/mostafa/Projects/forget/data/experiment3/inflammation,1,0.0014
file:/Users/mostafa/Projects/forget/data/experiment3/autoimmune-hemolytic-anemia,1,0.0014
file:/Users/mostafa/Projects/forget/data/experiment3/myeloblasts-under-10-percent-of-bone-marrow-nucleated-cells,1,0.0014
file:/Users/mostafa/Projects/forget/data/experiment3/liver-disease,3,0.0041
file:/Users/mostafa/Projects/forget/data/experiment3/veillonellaceae,1,0.0014
file:/Users/mostafa/Projects/forget/data/experiment3/desulfovibrio,1,0.0014
file:/Users/mostafa/Projects/forget/data/experiment3/chemotherapeutic-agents,1,0.0014
file:/Users/mostafa/Projects/forget/data/experiment3/non-neoplastic-liver-and-intrahepatic-bile-duct-disorder,1,0.0014
file:/Users/mostafa/Projects/forget/data/experiment3/acid-sensing-ion-channel-blockers,1,0.0014
file:/Users/mostafa/Projects/forget/data/experiment3/potassium-channel-blocker,1,0.0014
file:/Users/mostafa/Projects/forget/data/experiment3/increased-rate,2,0.0027
file:/Users/mostafa/Projects/forget/data/experiment3/tanespimycin,1,0.0014
file:/Users/mostafa/Projects/forget/data/experiment3/6alpha-methylprednisolone,1,0.0014
file:/Users/mostafa/Projects/forget/data/experiment3/purinergic-p2x-receptor-antagonists,1,0.0014
file:/Users/mostafa/Projects/forget/data/experiment3/dursun-syndrome,1,0.0014
file:/Users/mostafa/Projects/forget/data/experiment3/iloprost,1,0.0014
file:/Users/mostafa/Projects/forget/data/experiment3/non-neoplastic-hepatic-disorder,1,0.0014
file:/Users/mostafa/Projects/forget/data/experiment3/asia-Concept,1,0.0014
file:/Users/mostafa/Projects/forget/data/experiment3/purinergic-p2-receptor-agonists,1,0.0014
file:/Users/mostafa/Projects/forget/data/experiment3/chlorthenoxazine,2,0.0027
file:/Users/mostafa/Projects/forget/data/experiment3/aspirin-dipyridamole-drug-combination,1,0.0014
file:/Users/mostafa/Projects/forget/data/experiment3/reticular-dysgenesis,1,0.0014
file:/Users/mostafa/Projects/forget/data/experiment3/cocaine,1,0.0014
file:/Users/mostafa/Projects/forget/data/experiment3/switch-over-the-counter-drug,1,0.0014
file:/Users/mostafa/Projects/forget/data/experiment3/nutriment,1,0.0014
file:/Users/mostafa/Projects/forget/data/experiment3/bile-therapy-drug,1,0.0014
file:/Users/mostafa/Projects/forget/data/experiment3/designer-drugs,1,0.0014
file:/Users/mostafa/Projects/forget/data/experiment3/angiogenesis-inhibitor,1,0.0014
file:/Users/mostafa/Projects/forget/data/experiment3/drugs-of-the-same-category-and-clinical-effectiveness,1,0.0014
file:/Users/mostafa/Projects/forget/data/experiment3/desulfovibrio-gigas,2,0.0027
file:/Users/mostafa/Projects/forget/data/experiment3/mucolytic,1,0.0014
file:/Users/mostafa/Projects/forget/data/experiment3/ciprofibrate,1,0.0014
file:/Users/mostafa/Projects/forget/data/experiment3/leukocyte-disorder,1,0.0014
file:/Users/mostafa/Projects/forget/data/experiment3/ezetimibe-simvastatin-drug-combination,1,0.0014
file:/Users/mostafa/Projects/forget/data/experiment3/neocarzinostatin-chromophore,1,0.0014
file:/Users/mostafa/Projects/forget/data/experiment3/epithelial-sodium-channel-agonists,1,0.0014
file:/Users/mostafa/Projects/forget/data/experiment3/nonspecific-hepatitis,1,0.0014
file:/Users/mostafa/Projects/forget/data/experiment3/antitoxic-serum,1,0.0014
file:/Users/mostafa/Projects/forget/data/experiment3/dental-drug,1,0.0014
file:/Users/mostafa/Projects/forget/data/experiment3/gangrene,1,0.0014
file:/Users/mostafa/Projects/forget/data/experiment3/anti-dizziness-agent,1,0.0014
file:/Users/mostafa/Projects/forget/data/experiment3/expectorant,1,0.0014
file:/Users/mostafa/Projects/forget/data/experiment3/dose-of-medicine-to-be-taken-only-once,1,0.0014
file:/Users/mostafa/Projects/forget/data/experiment3/purinergic-p2y-receptor-agonists,1,0.0014
file:/Users/mostafa/Projects/forget/data/experiment3/placebo,1,0.0014
file:/Users/mostafa/Projects/forget/data/experiment3/lupus-hepatitis-syndrome,1,0.0014
file:/Users/mostafa/Projects/forget/data/experiment3/hepatitis-due-to-infection,1,0.0014
file:/Users/mostafa/Projects/forget/data/experiment3/receptor-modulator,1,0.0014
file:/Users/mostafa/Projects/forget/data/experiment3/ciprofloxacin,1,0.0014
file:/Users/mostafa/Projects/forget/data/experiment3/myeloblasts-under-5-percent-of-peripheral-blood-white-cells,1,0.0014
file:/Users/mostafa/Projects/forget/data/experiment3/dysplastic-erythroid-precursor,1,0.0014
file:/Users/mostafa/Projects/forget/data/experiment3/benserazide,1,0.0014
file:/Users/mostafa/Projects/forget/data/experiment3/single-drug,1,0.0014
file:/Users/mostafa/Projects/forget/data/experiment3/pioglitazone,1,0.0014
file:/Users/mostafa/Projects/forget/data/experiment3/alcohol-deterrent,1,0.0014
file:/Users/mostafa/Projects/forget/data/experiment3/sharp-nerve-pain,1,0.0014
file:/Users/mostafa/Projects/forget/data/experiment3/antineoplastic-agent,1,0.0014
file:/Users/mostafa/Projects/forget/data/experiment3/viral-hepatitis,1,0.0014
file:/Users/mostafa/Projects/forget/data/experiment3/asia-central,1,0.0014
file:/Users/mostafa/Projects/forget/data/experiment3/western-drugs,1,0.0014
file:/Users/mostafa/Projects/forget/data/experiment3/chronic-persistent-hepatitis,1,0.0014
file:/Users/mostafa/Projects/forget/data/experiment3/original-drug,1,0.0014
file:/Users/mostafa/Projects/forget/data/experiment3/12-diacyl-sn-glycero-3-phosphocholine-1-,1,0.0014
file:/Users/mostafa/Projects/forget/data/experiment3/ostreae-testa,1,0.0014
file:/Users/mostafa/Projects/forget/data/experiment3/armenia,1,0.0014
file:/Users/mostafa/Projects/forget/data/experiment3/neonatal-hepatitis,1,0.0014
file:/Users/mostafa/Projects/forget/data/experiment3/irritants,1,0.0014
file:/Users/mostafa/Projects/forget/data/experiment3/circulatory-drug,1,0.0014
file:/Users/mostafa/Projects/forget/data/experiment3/sugar-icing-liver,1,0.0014
file:/Users/mostafa/Projects/forget/data/experiment3/lithontriptic,1,0.0014
file:/Users/mostafa/Projects/forget/data/experiment3/hanot-kiener-syndrome,1,0.0014
file:/Users/mostafa/Projects/forget/data/experiment3/aphthous-ulcer,1,0.0014
file:/Users/mostafa/Projects/forget/data/experiment3/acetylsalicylic-acid,1,0.0014
file:/Users/mostafa/Projects/forget/data/experiment3/hormone-receptor-modulator,1,0.0014
file:/Users/mostafa/Projects/forget/data/experiment3/drug-use-measurement,1,0.0014
file:/Users/mostafa/Projects/forget/data/experiment3/monocytopenia,1,0.0014
file:/Users/mostafa/Projects/forget/data/experiment3/peginterferon-alfa-2a,1,0.0014
file:/Users/mostafa/Projects/forget/data/experiment3/artificial-perfusate,1,0.0014
file:/Users/mostafa/Projects/forget/data/experiment3/leukotriene-antagonists,1,0.0014
file:/Users/mostafa/Projects/forget/data/experiment3/bone-density-conservation-agent,1,0.0014
file:/Users/mostafa/Projects/forget/data/experiment3/abnormal,7,0.0095
file:/Users/mostafa/Projects/forget/data/experiment3/anti-angina-pectoris-drug,1,0.0014
file:/Users/mostafa/Projects/forget/data/experiment3/leukocyte-disorders,1,0.0014
file:/Users/mostafa/Projects/forget/data/experiment3/afghanistan,1,0.0014
file:/Users/mostafa/Projects/forget/data/experiment3/purinergic-p1-receptor-antagonists,1,0.0014
file:/Users/mostafa/Projects/forget/data/experiment3/n-desmethylclozapine,1,0.0014
file:/Users/mostafa/Projects/forget/data/experiment3/anti-hepatitis-c-virus-drug,1,0.0014
file:/Users/mostafa/Projects/forget/data/experiment3/off-label-medicine,1,0.0014
file:/Users/mostafa/Projects/forget/data/experiment3/russian-federation,1,0.0014
file:/Users/mostafa/Projects/forget/data/experiment3/perphenazine,1,0.0014
file:/Users/mostafa/Projects/forget/data/experiment3/azerbaijan,1,0.0014
file:/Users/mostafa/Projects/forget/data/experiment3/antilipemic-drug,1,0.0014
file:/Users/mostafa/Projects/forget/data/experiment3/acetylcholine-release-inhibitors,1,0.0014
file:/Users/mostafa/Projects/forget/data/experiment3/neuralgia-postherpetic,1,0.0014
file:/Users/mostafa/Projects/forget/data/experiment3/diclofenac-sodium,1,0.0014
file:/Users/mostafa/Projects/forget/data/experiment3/nilotinib,1,0.0014
file:/Users/mostafa/Projects/forget/data/experiment3/valproic-acid,1,0.0014
file:/Users/mostafa/Projects/forget/data/experiment3/isotretinoin,1,0.0014
file:/Users/mostafa/Projects/forget/data/experiment3/insulin,1,0.0014
file:/Users/mostafa/Projects/forget/data/experiment3/nervous-tissue-neoplasm,1,0.0014
file:/Users/mostafa/Projects/forget/data/experiment3/sodium-valproate,1,0.0014
file:/Users/mostafa/Projects/forget/data/experiment3/receptor-antagonist,1,0.0014
file:/Users/mostafa/Projects/forget/data/experiment3/post-infectious-neuralgia,2,0.0027
file:/Users/mostafa/Projects/forget/data/experiment3/buprenorphine-naloxone-drug-combination,1,0.0014
file:/Users/mostafa/Projects/forget/data/experiment3/autoimmune-hepatitis,2,0.0027
file:/Users/mostafa/Projects/forget/data/experiment3/anti-allergic-agent,1,0.0014
file:/Users/mostafa/Projects/forget/data/experiment3/maldives,1,0.0014
file:/Users/mostafa/Projects/forget/data/experiment3/agonist,1,0.0014
file:/Users/mostafa/Projects/forget/data/experiment3/antitumor-drug,1,0.0014
file:/Users/mostafa/Projects/forget/data/experiment3/basic-drugs,1,0.0014
file:/Users/mostafa/Projects/forget/data/experiment3/sevoflurane,1,0.0014
file:/Users/mostafa/Projects/forget/data/experiment3/mtor-inhibitor,1,0.0014
file:/Users/mostafa/Projects/forget/data/experiment3/pediatric-drug,1,0.0014
file:/Users/mostafa/Projects/forget/data/experiment3/sodium-lactate,1,0.0014
file:/Users/mostafa/Projects/forget/data/experiment3/hematologic-gastrointestinal-and-renal-agents,1,0.0014
file:/Users/mostafa/Projects/forget/data/experiment3/vulnerary,1,0.0014
file:/Users/mostafa/Projects/forget/data/experiment3/busulfan,1,0.0014
file:/Users/mostafa/Projects/forget/data/experiment3/unused-drug,1,0.0014
file:/Users/mostafa/Projects/forget/data/experiment3/leukopenia,25,0.0339
file:/Users/mostafa/Projects/forget/data/experiment3/loss-of-chromosome-5q,1,0.0014
file:/Users/mostafa/Projects/forget/data/experiment3/anti-asthmatic-agent,1,0.0014
file:/Users/mostafa/Projects/forget/data/experiment3/haloperidol,1,0.0014
file:/Users/mostafa/Projects/forget/data/experiment3/bringing-medicine,1,0.0014
file:/Users/mostafa/Projects/forget/data/experiment3/generic-medicine,1,0.0014
file:/Users/mostafa/Projects/forget/data/experiment3/mydriatic-agent,1,0.0014
file:/Users/mostafa/Projects/forget/data/experiment3/nocodazole,1,0.0014
file:/Users/mostafa/Projects/forget/data/experiment3/malaysia,1,0.0014
file:/Users/mostafa/Projects/forget/data/experiment3/nicotine-preparation,1,0.0014
file:/Users/mostafa/Projects/forget/data/experiment3/india,1,0.0014
file:/Users/mostafa/Projects/forget/data/experiment3/-1r3s--3--adamantan-1-yl--1--aminomethyl--34-dihydroisochromene-56-diol-hydrochloride,1,0.0014
file:/Users/mostafa/Projects/forget/data/experiment3/web-2086,1,0.0014
file:/Users/mostafa/Projects/forget/data/experiment3/colchicine,1,0.0014
file:/Users/mostafa/Projects/forget/data/experiment3/estrogens-conjugated--usp-,1,0.0014
file:/Users/mostafa/Projects/forget/data/experiment3/controlled-substances,1,0.0014
file:/Users/mostafa/Projects/forget/data/experiment3/endothelin-antagonist,1,0.0014
file:/Users/mostafa/Projects/forget/data/experiment3/protein-kinase-c-inhibitor,1,0.0014
file:/Users/mostafa/Projects/forget/data/experiment3/5-fluorouracil,1,0.0014
file:/Users/mostafa/Projects/forget/data/experiment3/angiotensin-antagonist,1,0.0014
file:/Users/mostafa/Projects/forget/data/experiment3/bronchodilator-agent,1,0.0014
file:/Users/mostafa/Projects/forget/data/experiment3/radiopharmaceutical,1,0.0014
file:/Users/mostafa/Projects/forget/data/experiment3/nutraceutical,1,0.0014
file:/Users/mostafa/Projects/forget/data/experiment3/new-drug,1,0.0014
file:/Users/mostafa/Projects/forget/data/experiment3/trichloroethylene,1,0.0014
file:/Users/mostafa/Projects/forget/data/experiment3/antifungal-agent,1,0.0014
file:/Users/mostafa/Projects/forget/data/experiment3/british-indian-ocean-territory,1,0.0014
file:/Users/mostafa/Projects/forget/data/experiment3/liver,2,0.0027
file:/Users/mostafa/Projects/forget/data/experiment3/korea-democratic-peoples-republic-of,1,0.0014
file:/Users/mostafa/Projects/forget/data/experiment3/fluconazole,1,0.0014
file:/Users/mostafa/Projects/forget/data/experiment3/vitamin-k-antagonist,1,0.0014
file:/Users/mostafa/Projects/forget/data/experiment3/isoflurane,1,0.0014
file:/Users/mostafa/Projects/forget/data/experiment3/glandular-fever-hepatitis,1,0.0014
file:/Users/mostafa/Projects/forget/data/experiment3/antifungal-drug,2,0.0027
file:/Users/mostafa/Projects/forget/data/experiment3/analgesic,1,0.0014
file:/Users/mostafa/Projects/forget/data/experiment3/crude-drug,1,0.0014
file:/Users/mostafa/Projects/forget/data/experiment3/mefloquine,1,0.0014
file:/Users/mostafa/Projects/forget/data/experiment3/continuant,4,0.0054
file:/Users/mostafa/Projects/forget/data/experiment3/8--3-chlorostyryl--caffeine,1,0.0014
file:/Users/mostafa/Projects/forget/data/experiment3/rosiglitazone,1,0.0014
file:/Users/mostafa/Projects/forget/data/experiment3/carboplatin,1,0.0014
file:/Users/mostafa/Projects/forget/data/experiment3/turkmenistan,1,0.0014
file:/Users/mostafa/Projects/forget/data/experiment3/hodgkins-lymphoma,2,0.0027
file:/Users/mostafa/Projects/forget/data/experiment3/substance--life-science-,1,0.0014
file:/Users/mostafa/Projects/forget/data/experiment3/disseminated-intravascular-coagulation,1,0.0014
file:/Users/mostafa/Projects/forget/data/experiment3/drug-efflux-pump-inhibitors,1,0.0014
file:/Users/mostafa/Projects/forget/data/experiment3/drugs-of-abuse,1,0.0014
file:/Users/mostafa/Projects/forget/data/experiment3/renal-excretion-drugs,1,0.0014
file:/Users/mostafa/Projects/forget/data/experiment3/---alpha-tocopherol,1,0.0014
file:/Users/mostafa/Projects/forget/data/experiment3/macrocytic-anemia,1,0.0014
file:/Users/mostafa/Projects/forget/data/experiment3/designated-drugs,1,0.0014
file:/Users/mostafa/Projects/forget/data/experiment3/genistein,1,0.0014
file:/Users/mostafa/Projects/forget/data/experiment3/oxytocic,1,0.0014
file:/Users/mostafa/Projects/forget/data/experiment3/chromosome-5,1,0.0014
file:/Users/mostafa/Projects/forget/data/experiment3/purinergic-antagonist,1,0.0014
file:/Users/mostafa/Projects/forget/data/experiment3/abnormality-of-the-endocrine-system,1,0.0014
file:/Users/mostafa/Projects/forget/data/experiment3/antineoplastic-and-immunosuppressive-agents,1,0.0014
file:/Users/mostafa/Projects/forget/data/experiment3/thromboxane-antagonist,1,0.0014
file:/Users/mostafa/Projects/forget/data/experiment3/decoy-type-nucleic-acid-medicine,1,0.0014
file:/Users/mostafa/Projects/forget/data/experiment3/diagnostic-drug,1,0.0014
file:/Users/mostafa/Projects/forget/data/experiment3/etoposide,1,0.0014
file:/Users/mostafa/Projects/forget/data/experiment3/counterfeit-drugs,1,0.0014
file:/Users/mostafa/Projects/forget/data/experiment3/daily-applied-medicine,1,0.0014
file:/Users/mostafa/Projects/forget/data/experiment3/bhutan,1,0.0014
file:/Users/mostafa/Projects/forget/data/experiment3/nonsteroidal-antiinflammatory-drug,1,0.0014
file:/Users/mostafa/Projects/forget/data/experiment3/hepatomegaly,1,0.0014
file:/Users/mostafa/Projects/forget/data/experiment3/nikkajicompounds,1,0.0014
file:/Users/mostafa/Projects/forget/data/experiment3/diabetes-mellitus,2,0.0027
file:/Users/mostafa/Projects/forget/data/experiment3/cyclin-dependent-kinase-inhibitor-p57,1,0.0014
file:/Users/mostafa/Projects/forget/data/experiment3/animal-medicine,1,0.0014
file:/Users/mostafa/Projects/forget/data/experiment3/pegvisomant,1,0.0014
file:/Users/mostafa/Projects/forget/data/experiment3/membrane-transport-modulators,1,0.0014
file:/Users/mostafa/Projects/forget/data/experiment3/natural-medicine,1,0.0014
file:/Users/mostafa/Projects/forget/data/experiment3/interface-hepatitis,1,0.0014
file:/Users/mostafa/Projects/forget/data/experiment3/granulomatous-hepatitis,1,0.0014
file:/Users/mostafa/Projects/forget/data/experiment3/benzodiazepine,1,0.0014
file:/Users/mostafa/Projects/forget/data/experiment3/radioprotective-drug,1,0.0014
file:/Users/mostafa/Projects/forget/data/experiment3/fluoxetine,1,0.0014
file:/Users/mostafa/Projects/forget/data/experiment3/calcineurin,1,0.0014
file:/Users/mostafa/Projects/forget/data/experiment3/hormones-hormone-substitutes-and-hormone-antagonists,1,0.0014
file:/Users/mostafa/Projects/forget/data/experiment3/9-cis-retinoic-acid,1,0.0014
file:/Users/mostafa/Projects/forget/data/experiment3/osteosclerosis,1,0.0014
file:/Users/mostafa/Projects/forget/data/experiment3/causative-agent,1,0.0014
file:/Users/mostafa/Projects/forget/data/experiment3/anti-allergic-and-respiratory-system-agents,1,0.0014
file:/Users/mostafa/Projects/forget/data/experiment3/pharmaceutical,1,0.0014
file:/Users/mostafa/Projects/forget/data/experiment3/herpes-zoster,1,0.0014
file:/Users/mostafa/Projects/forget/data/experiment3/kyrgyzstan,1,0.0014
file:/Users/mostafa/Projects/forget/data/experiment3/selenomonas,6,0.0081
file:/Users/mostafa/Projects/forget/data/experiment3/anticonvulsant-agent,1,0.0014
file:/Users/mostafa/Projects/forget/data/experiment3/potassium-channel-activator,1,0.0014
file:/Users/mostafa/Projects/forget/data/experiment3/amlodipine-besylate-olmesartan-medoxomil-drug-combination,1,0.0014
file:/Users/mostafa/Projects/forget/data/experiment3/astringent,1,0.0014
file:/Users/mostafa/Projects/forget/data/experiment3/pakistan,1,0.0014
file:/Users/mostafa/Projects/forget/data/experiment3/fulminant-hepatitis,1,0.0014
file:/Users/mostafa/Projects/forget/data/experiment3/hepatitis-animal,1,0.0014
file:/Users/mostafa/Projects/forget/data/experiment3/anti-inflammatory-agents-antirheumatic-agents-and-inflammation-mediators,1,0.0014
file:/Users/mostafa/Projects/forget/data/experiment3/enzyme-inhibitor-drugs,1,0.0014
file:/Users/mostafa/Projects/forget/data/experiment3/drug-hypersensitive,2,0.0027
file:/Users/mostafa/Projects/forget/data/experiment3/radicicol,1,0.0014
file:/Users/mostafa/Projects/forget/data/experiment3/performance-enhancing-substances,1,0.0014
file:/Users/mostafa/Projects/forget/data/experiment3/dimemorfan,8,0.0109
file:/Users/mostafa/Projects/forget/data/experiment3/peptide-inhibitor,1,0.0014
file:/Users/mostafa/Projects/forget/data/experiment3/vasodilator-agent,1,0.0014
file:/Users/mostafa/Projects/forget/data/experiment3/epithelial-sodium-channel-blockers,1,0.0014
file:/Users/mostafa/Projects/forget/data/experiment3/cell-based-drug,1,0.0014
file:/Users/mostafa/Projects/forget/data/experiment3/interleukin-1-receptor-antagonist,1,0.0014
file:/Users/mostafa/Projects/forget/data/experiment3/partial-agonist,1,0.0014
file:/Users/mostafa/Projects/forget/data/experiment3/methamphetamine,1,0.0014
file:/Users/mostafa/Projects/forget/data/experiment3/gastrointestinal-drug,1,0.0014
file:/Users/mostafa/Projects/forget/data/experiment3/emtricitabine-rilpivirine-tenofovir-drug-combination,1,0.0014
file:/Users/mostafa/Projects/forget/data/experiment3/spirochete-infection,1,0.0014
file:/Users/mostafa/Projects/forget/data/experiment3/polynuclear-aromatic-compound,1,0.0014
file:/Users/mostafa/Projects/forget/data/experiment3/gram-negative-anaerobic-straight-curved-and-helical-rods,1,0.0014
file:/Users/mostafa/Projects/forget/data/experiment3/lh-rh-agonist,1,0.0014
file:/Users/mostafa/Projects/forget/data/experiment3/hla-dq-alpha-chains,4,0.0054
file:/Users/mostafa/Projects/forget/data/experiment3/serinethreonine-protein-kinase-mtor,1,0.0014
file:/Users/mostafa/Projects/forget/data/experiment3/mesalamine,1,0.0014
file:/Users/mostafa/Projects/forget/data/experiment3/serotonin-agonist,1,0.0014
file:/Users/mostafa/Projects/forget/data/experiment3/ppar-agonist,1,0.0014
file:/Users/mostafa/Projects/forget/data/experiment3/molecular-targeting-drug,1,0.0014
file:/Users/mostafa/Projects/forget/data/experiment3/spiramide,1,0.0014
file:/Users/mostafa/Projects/forget/data/experiment3/neurotransmitter-agent,1,0.0014
file:/Users/mostafa/Projects/forget/data/experiment3/cyclin-dependent-kinase-inhibitor-p19,1,0.0014
file:/Users/mostafa/Projects/forget/data/experiment3/protein-kinase-inhibitors,22,0.0299
file:/Users/mostafa/Projects/forget/data/experiment3/cyclin-dependent-kinase-inhibitor-p18,1,0.0014
file:/Users/mostafa/Projects/forget/data/experiment3/morphinans,1,0.0014
file:/Users/mostafa/Projects/forget/data/experiment3/cyclin-dependent-kinase-inhibitor-p15,1,0.0014
file:/Users/mostafa/Projects/forget/data/experiment3/viral-disease,1,0.0014
file:/Users/mostafa/Projects/forget/data/experiment3/heart,2,0.0027
file:/Users/mostafa/Projects/forget/data/experiment3/cyclin-dependent-kinase-inhibitor-p21,1,0.0014
file:/Users/mostafa/Projects/forget/data/experiment3/antitussive,1,0.0014
file:/Users/mostafa/Projects/forget/data/experiment3/biological-preparation,1,0.0014
file:/Users/mostafa/Projects/forget/data/experiment3/scopolamine,1,0.0014
file:/Users/mostafa/Projects/forget/data/experiment3/moving-drug-to-inside-of-hepatocyte,1,0.0014
file:/Users/mostafa/Projects/forget/data/experiment3/cyclin-dependent-kinase-inhibitor-p27,1,0.0014
file:/Users/mostafa/Projects/forget/data/experiment3/hormone-preparation,1,0.0014
file:/Users/mostafa/Projects/forget/data/experiment3/cytarabine,1,0.0014
file:/Users/mostafa/Projects/forget/data/experiment3/abnormal-liver-morphology,1,0.0014
file:/Users/mostafa/Projects/forget/data/experiment3/drugs-non-prescription,1,0.0014
file:/Users/mostafa/Projects/forget/data/experiment3/breast-cancer-diagnosis,2,0.0027
file:/Users/mostafa/Projects/forget/data/experiment3/immunomodulator,1,0.0014
file:/Users/mostafa/Projects/forget/data/experiment3/cxcr4-inhibitor,1,0.0014
file:/Users/mostafa/Projects/forget/data/experiment3/tamoxifen,1,0.0014
file:/Users/mostafa/Projects/forget/data/experiment3/rare-bacterial-infectious-disease,1,0.0014
file:/Users/mostafa/Projects/forget/data/experiment3/nonalcoholic-steatohepatitis,1,0.0014
file:/Users/mostafa/Projects/forget/data/experiment3/-1s2r--5-methoxy-1-methyl-2--propylamino-tetralin-hydrochloride,1,0.0014
file:/Users/mostafa/Projects/forget/data/experiment3/antihistaminic,1,0.0014
file:/Users/mostafa/Projects/forget/data/experiment3/angiotensin-converting-enzyme-activity-measurement,1,0.0014
file:/Users/mostafa/Projects/forget/data/experiment3/acute-hepatitis,1,0.0014
file:/Users/mostafa/Projects/forget/data/experiment3/long-term-managed-drug,1,0.0014
file:/Users/mostafa/Projects/forget/data/experiment3/cholenes,1,0.0014
file:/Users/mostafa/Projects/forget/data/experiment3/tetrabenazine,1,0.0014
file:/Users/mostafa/Projects/forget/data/experiment3/kainic-acid,1,0.0014
file:/Users/mostafa/Projects/forget/data/experiment3/non-regulated-medicine,1,0.0014
file:/Users/mostafa/Projects/forget/data/experiment3/increased-inflammatory-response,1,0.0014
file:/Users/mostafa/Projects/forget/data/experiment3/gout-suppressant,1,0.0014
file:/Users/mostafa/Projects/forget/data/experiment3/myanmar,1,0.0014
file:/Users/mostafa/Projects/forget/data/experiment3/thiostrepton,1,0.0014
file:/Users/mostafa/Projects/forget/data/experiment3/emodin,1,0.0014
file:/Users/mostafa/Projects/forget/data/experiment3/neurotransmitters-and-neurotransmitter-agents,1,0.0014
file:/Users/mostafa/Projects/forget/data/experiment3/dementia,1,0.0014
file:/Users/mostafa/Projects/forget/data/experiment3/lao-peoples-democratic-republic,1,0.0014
file:/Users/mostafa/Projects/forget/data/experiment3/calmodulin-antagonist,1,0.0014
file:/Users/mostafa/Projects/forget/data/experiment3/geriatrics,1,0.0014
file:/Users/mostafa/Projects/forget/data/experiment3/anthelmintic,1,0.0014
file:/Users/mostafa/Projects/forget/data/experiment3/bortezomib,1,0.0014
file:/Users/mostafa/Projects/forget/data/experiment3/argentaffinoma,1,0.0014
file:/Users/mostafa/Projects/forget/data/experiment3/proteasome-inhibitor,1,0.0014
file:/Users/mostafa/Projects/forget/data/experiment3/heart-disease,1,0.0014
file:/Users/mostafa/Projects/forget/data/experiment3/christmas-island,1,0.0014
file:/Users/mostafa/Projects/forget/data/experiment3/ivermectin,1,0.0014
file:/Users/mostafa/Projects/forget/data/experiment3/morphine,1,0.0014
file:/Users/mostafa/Projects/forget/data/experiment3/integumentary-preparation,1,0.0014
file:/Users/mostafa/Projects/forget/data/experiment3/zotarolimus,1,0.0014
file:/Users/mostafa/Projects/forget/data/experiment3/chlorpromazine,1,0.0014
file:/Users/mostafa/Projects/forget/data/experiment3/pharmaceutical-preparations,1,0.0014
file:/Users/mostafa/Projects/forget/data/experiment3/continent,1,0.0014
file:/Users/mostafa/Projects/forget/data/experiment3/hematologic-agent,1,0.0014
file:/Users/mostafa/Projects/forget/data/experiment3/toxic-hepatitis,1,0.0014
file:/Users/mostafa/Projects/forget/data/experiment3/caustics,1,0.0014
file:/Users/mostafa/Projects/forget/data/experiment3/russells-viper,2,0.0027
file:/Users/mostafa/Projects/forget/data/experiment3/myeloablative-agonists,1,0.0014
file:/Users/mostafa/Projects/forget/data/experiment3/paf-antagonist,1,0.0014
file:/Users/mostafa/Projects/forget/data/experiment3/purinergic-p2x-receptor-agonists,1,0.0014
file:/Users/mostafa/Projects/forget/data/experiment3/proliferation-signal-inhibitors,1,0.0014
file:/Users/mostafa/Projects/forget/data/experiment3/antacid,1,0.0014
file:/Users/mostafa/Projects/forget/data/experiment3/caesium-chloride,1,0.0014
file:/Users/mostafa/Projects/forget/data/experiment3/topotecan,1,0.0014
file:/Users/mostafa/Projects/forget/data/experiment3/exendin-4,1,0.0014
file:/Users/mostafa/Projects/forget/data/experiment3/thailand,1,0.0014
file:/Users/mostafa/Projects/forget/data/experiment3/parthenolide,1,0.0014
file:/Users/mostafa/Projects/forget/data/experiment3/pimozide,1,0.0014
file:/Users/mostafa/Projects/forget/data/experiment3/medical-drug,1,0.0014
file:/Users/mostafa/Projects/forget/data/experiment3/moviprep,1,0.0014
file:/Users/mostafa/Projects/forget/data/experiment3/bucladesine,1,0.0014
file:/Users/mostafa/Projects/forget/data/experiment3/myelodysplastic-syndrome,1,0.0014
file:/Users/mostafa/Projects/forget/data/experiment3/anti-ulcer-drug,1,0.0014
file:/Users/mostafa/Projects/forget/data/experiment3/mouth-diseases,1,0.0014
file:/Users/mostafa/Projects/forget/data/experiment3/abnormal-leukocyte-morphology,1,0.0014
file:/Users/mostafa/Projects/forget/data/experiment3/myeloblasts-under-5-percent-of-bone-marrow-nucleated-cells,1,0.0014
file:/Users/mostafa/Projects/forget/data/experiment3/drug-for-treatment-of-bone-disease,1,0.0014
file:/Users/mostafa/Projects/forget/data/experiment3/chloride-channel-blocker,1,0.0014
file:/Users/mostafa/Projects/forget/data/experiment3/antitussive-drug,1,0.0014
file:/Users/mostafa/Projects/forget/data/experiment3/insoluble-drug,1,0.0014
file:/Users/mostafa/Projects/forget/data/experiment3/ppar-gamma-agonist,1,0.0014
file:/Users/mostafa/Projects/forget/data/experiment3/n-methylquipazine-dimaleate,1,0.0014
file:/Users/mostafa/Projects/forget/data/experiment3/streptozotocin,1,0.0014
file:/Users/mostafa/Projects/forget/data/experiment3/neuromuscular-agent,1,0.0014
file:/Users/mostafa/Projects/forget/data/experiment3/asia,45,0.0611
file:/Users/mostafa/Projects/forget/data/experiment3/nimodipine,1,0.0014
file:/Users/mostafa/Projects/forget/data/experiment3/noma-Concept,2,0.0027
file:/Users/mostafa/Projects/forget/data/experiment3/overt-primary-myelofibrosis,1,0.0014
file:/Users/mostafa/Projects/forget/data/experiment3/chronic-hepatitis,1,0.0014
file:/Users/mostafa/Projects/forget/data/experiment3/budesonide-formoterol-fumarate-drug-combination,1,0.0014
file:/Users/mostafa/Projects/forget/data/experiment3/surface-antigen,1,0.0014
file:/Users/mostafa/Projects/forget/data/experiment3/glycols,1,0.0014
file:/Users/mostafa/Projects/forget/data/experiment3/exclusively-for-drugs,1,0.0014
file:/Users/mostafa/Projects/forget/data/experiment3/prescription-drugs,1,0.0014
file:/Users/mostafa/Projects/forget/data/experiment3/androgen-antagonist,1,0.0014
file:/Users/mostafa/Projects/forget/data/experiment3/n-octylhomovanillamide,1,0.0014
file:/Users/mostafa/Projects/forget/data/experiment3/rare,1,0.0014
file:/Users/mostafa/Projects/forget/data/experiment3/pi3k-inhibitor,1,0.0014
file:/Users/mostafa/Projects/forget/data/experiment3/immune-system,1,0.0014
file:/Users/mostafa/Projects/forget/data/experiment3/drug-resistant,2,0.0027
file:/Users/mostafa/Projects/forget/data/experiment3/phenylephrine,1,0.0014
file:/Users/mostafa/Projects/forget/data/experiment3/tobramycin,1,0.0014
file:/Users/mostafa/Projects/forget/data/experiment3/secondary-syphilitic-hepatitis,1,0.0014
file:/Users/mostafa/Projects/forget/data/experiment3/butylene-glycols,4,0.0054
file:/Users/mostafa/Projects/forget/data/experiment3/timor-leste,1,0.0014
file:/Users/mostafa/Projects/forget/data/experiment3/pentamidine,1,0.0014
file:/Users/mostafa/Projects/forget/data/experiment3/estrogen-receptor-modulator,1,0.0014
file:/Users/mostafa/Projects/forget/data/experiment3/hypertension,1,0.0014
file:/Users/mostafa/Projects/forget/data/experiment3/dermatologic-drug,1,0.0014
file:/Users/mostafa/Projects/forget/data/experiment3/ulcer,1,0.0014
file:/Users/mostafa/Projects/forget/data/experiment3/leading-drugs,1,0.0014
file:/Users/mostafa/Projects/forget/data/experiment3/5-nonyloxytryptamine-oxalate,1,0.0014
file:/Users/mostafa/Projects/forget/data/experiment3/behind-the-counter-drugs,1,0.0014
file:/Users/mostafa/Projects/forget/data/experiment3/peripheral-nervous-system-drug,1,0.0014
file:/Users/mostafa/Projects/forget/data/experiment3/emetic,1,0.0014
file:/Users/mostafa/Projects/forget/data/experiment3/epigallocatechin-gallate,1,0.0014
file:/Users/mostafa/Projects/forget/data/experiment3/organic-compound,5,0.0068
file:/Users/mostafa/Projects/forget/data/experiment3/disease,1,0.0014
file:/Users/mostafa/Projects/forget/data/experiment3/levetiracetam,1,0.0014
file:/Users/mostafa/Projects/forget/data/experiment3/hyperglycemic-agent,1,0.0014
file:/Users/mostafa/Projects/forget/data/experiment3/antiparkinson-drug,1,0.0014
file:/Users/mostafa/Projects/forget/data/experiment3/tert-butyl-hydroperoxide,1,0.0014
file:/Users/mostafa/Projects/forget/data/experiment3/losartan,1,0.0014
file:/Users/mostafa/Projects/forget/data/experiment3/paracetamol,1,0.0014
file:/Users/mostafa/Projects/forget/data/experiment3/radiosensitizing-agent,1,0.0014
file:/Users/mostafa/Projects/forget/data/experiment3/dibenzazepines,1,0.0014
file:/Users/mostafa/Projects/forget/data/experiment3/eoi,1,0.0014
file:/Users/mostafa/Projects/forget/data/experiment3/decreased-amount,1,0.0014
file:/Users/mostafa/Projects/forget/data/experiment3/esterified-estrogen,1,0.0014
file:/Users/mostafa/Projects/forget/data/experiment3/cyclin-dependent-kinase-inhibitor-proteins,1,0.0014
file:/Users/mostafa/Projects/forget/data/experiment3/interleukin-6-inhibitor,1,0.0014
file:/Users/mostafa/Projects/forget/data/experiment3/alpha-adrenergic-agonist,1,0.0014
file:/Users/mostafa/Projects/forget/data/experiment3/anti-ulcer-agents,1,0.0014
file:/Users/mostafa/Projects/forget/data/experiment3/ischaemic-hepatitis,1,0.0014
file:/Users/mostafa/Projects/forget/data/experiment3/atypical-or-prolonged-hepatitis,1,0.0014
file:/Users/mostafa/Projects/forget/data/experiment3/roxindole,1,0.0014
file:/Users/mostafa/Projects/forget/data/experiment3/decreased-leukocyte-cell-number,1,0.0014
file:/Users/mostafa/Projects/forget/data/experiment3/leukoerythroblastic-reaction,1,0.0014
file:/Users/mostafa/Projects/forget/data/experiment3/caerulein,1,0.0014
file:/Users/mostafa/Projects/forget/data/experiment3/forming-a-complex-of-drugs-and-biological-substance,1,0.0014
file:/Users/mostafa/Projects/forget/data/experiment3/adapalene-benzoyl-peroxide-drug-combination,1,0.0014
file:/Users/mostafa/Projects/forget/data/experiment3/diclofenac,1,0.0014
file:/Users/mostafa/Projects/forget/data/experiment3/amorolfine-hydrochloride,5,0.0068
file:/Users/mostafa/Projects/forget/data/experiment3/reproductive-control-drug,1,0.0014
file:/Users/mostafa/Projects/forget/data/experiment3/poorly-absorbable-drugs,1,0.0014
file:/Users/mostafa/Projects/forget/data/experiment3/UMLS_Concept,5,0.0068
file:/Users/mostafa/Projects/forget/data/experiment3/loxtidine,1,0.0014
file:/Users/mostafa/Projects/forget/data/experiment3/fenoldopam,1,0.0014
file:/Users/mostafa/Projects/forget/data/experiment3/cdk-inhibitor,1,0.0014
file:/Users/mostafa/Projects/forget/data/experiment3/mongolia,1,0.0014
file:/Users/mostafa/Projects/forget/data/experiment3/vipera,1,0.0014
file:/Users/mostafa/Projects/forget/data/experiment3/substance-with-drug-role,1,0.0014
file:/Users/mostafa/Projects/forget/data/experiment3/anti-estrogen,1,0.0014
file:/Users/mostafa/Projects/forget/data/experiment3/angiotensin-converting-enzyme-measurement,1,0.0014
file:/Users/mostafa/Projects/forget/data/experiment3/feline-panleukopenia,1,0.0014
file:/Users/mostafa/Projects/forget/data/experiment3/nebivolol,2,0.0027
file:/Users/mostafa/Projects/forget/data/experiment3/indonesia,1,0.0014
file:/Users/mostafa/Projects/forget/data/experiment3/CHV_Concept,4,0.0054
file:/Users/mostafa/Projects/forget/data/experiment3/simvastatin,1,0.0014
file:/Users/mostafa/Projects/forget/data/experiment3/5-aza-2-deoxycytidine,1,0.0014
file:/Users/mostafa/Projects/forget/data/experiment3/geriatric-psychiatry,4,0.0054
file:/Users/mostafa/Projects/forget/data/experiment3/carcinoma,1,0.0014
file:/Users/mostafa/Projects/forget/data/experiment3/chloroquine,1,0.0014
file:/Users/mostafa/Projects/forget/data/experiment3/gene-therapeutic-agent,1,0.0014
file:/Users/mostafa/Projects/forget/data/experiment3/ochratoxin-a,1,0.0014
file:/Users/mostafa/Projects/forget/data/experiment3/antipyretics,1,0.0014
file:/Users/mostafa/Projects/forget/data/experiment3/benzothiadiazole,1,0.0014
file:/Users/mostafa/Projects/forget/data/experiment3/angiogenesis-modulating-agents,1,0.0014
file:/Users/mostafa/Projects/forget/data/experiment3/enzyme-inhibitor,2,0.0027
file:/Users/mostafa/Projects/forget/data/experiment3/antihyperplasia-drug,1,0.0014
file:/Users/mostafa/Projects/forget/data/experiment3/pharmaceutical-preparation,2,0.0027
file:/Users/mostafa/Projects/forget/data/experiment3/afimoxifene,1,0.0014
file:/Users/mostafa/Projects/forget/data/experiment3/chemical-entity,2,0.0027
file:/Users/mostafa/Projects/forget/data/experiment3/tyrosine-kinase-inhibitor,1,0.0014
file:/Users/mostafa/Projects/forget/data/experiment3/moving-drug-to-the-inside-of-liver,1,0.0014
file:/Users/mostafa/Projects/forget/data/experiment3/purinergic-agents,1,0.0014
file:/Users/mostafa/Projects/forget/data/experiment3/olmesartan,1,0.0014
file:/Users/mostafa/Projects/forget/data/experiment3/hepatitis-cholestatic,1,0.0014
file:/Users/mostafa/Projects/forget/data/experiment3/angiogenesis-inducing-agents,1,0.0014
file:/Users/mostafa/Projects/forget/data/experiment3/hemorrhage,1,0.0014
file:/Users/mostafa/Projects/forget/data/experiment3/drug-for-respiratory-system,1,0.0014
file:/Users/mostafa/Projects/forget/data/experiment3/rare-disease-in-plastic-and-reconstructive-surgery,1,0.0014
file:/Users/mostafa/Projects/forget/data/experiment3/cardiovascular-drug,1,0.0014
file:/Users/mostafa/Projects/forget/data/experiment3/protein-preparation,1,0.0014
file:/Users/mostafa/Projects/forget/data/experiment3/renal-agent,1,0.0014
file:/Users/mostafa/Projects/forget/data/experiment3/propylparaben,1,0.0014
file:/Users/mostafa/Projects/forget/data/experiment3/viet-nam,1,0.0014
file:/Users/mostafa/Projects/forget/data/experiment3/stimulants-historical,1,0.0014
file:/Users/mostafa/Projects/forget/data/experiment3/estrogen-receptor-antagonist,1,0.0014
file:/Users/mostafa/Projects/forget/data/experiment3/paclitaxel,1,0.0014
file:/Users/mostafa/Projects/forget/data/experiment3/ophthalmology-drug,1,0.0014
file:/Users/mostafa/Projects/forget/data/experiment3/leukocyte-disease,1,0.0014
file:/Users/mostafa/Projects/forget/data/experiment3/6-propyl-2-thiouracil,1,0.0014
file:/Users/mostafa/Projects/forget/data/experiment3/hepatitis-due-to-toxoplasmosis,1,0.0014
file:/Users/mostafa/Projects/forget/data/experiment3/carcinoid-tumor,1,0.0014
file:/Users/mostafa/Projects/forget/data/experiment3/lisinopril,1,0.0014
file:/Users/mostafa/Projects/forget/data/experiment3/celastrol,1,0.0014
file:/Users/mostafa/Projects/forget/data/experiment3/smoking-cessation-aid,1,0.0014
file:/Users/mostafa/Projects/forget/data/experiment3/extramedullary-hematopoiesis,1,0.0014
file:/Users/mostafa/Projects/forget/data/experiment3/chlorhexidine,1,0.0014
file:/Users/mostafa/Projects/forget/data/experiment3/butein,1,0.0014
file:/Users/mostafa/Projects/forget/data/experiment3/morphinan-alkaloid,1,0.0014
file:/Users/mostafa/Projects/forget/data/experiment3/central-nervous-system-drug,1,0.0014
file:/Users/mostafa/Projects/forget/data/experiment3/nafadotride,1,0.0014
file:/Users/mostafa/Projects/forget/data/experiment3/icterohepatitis,1,0.0014
file:/Users/mostafa/Projects/forget/data/experiment3/drug-allergen,1,0.0014
file:/Users/mostafa/Projects/forget/data/experiment3/inflammatory-response,2,0.0027
file:/Users/mostafa/Projects/forget/data/experiment3/internal-medicine,1,0.0014
file:/Users/mostafa/Projects/forget/data/experiment3/geriatric-psychiatry-Concept,2,0.0027
file:/Users/mostafa/Projects/forget/data/experiment3/antiinfective-agent,1,0.0014
file:/Users/mostafa/Projects/forget/data/experiment3/cisplatin,1,0.0014
file:/Users/mostafa/Projects/forget/data/experiment3/flucloxacillin,1,0.0014
file:/Users/mostafa/Projects/forget/data/experiment3/nervinum,1,0.0014
file:/Users/mostafa/Projects/forget/data/experiment3/nevirapine,1,0.0014
file:/Users/mostafa/Projects/forget/data/experiment3/disulfides,1,0.0014
file:/Users/mostafa/Projects/forget/data/experiment3/ciglitazone,1,0.0014
file:/Users/mostafa/Projects/forget/data/experiment3/abnormal-leukocyte-count,1,0.0014
file:/Users/mostafa/Projects/forget/data/experiment3/hla-dq,1,0.0014
file:/Users/mostafa/Projects/forget/data/experiment3/adenosine-agonist,1,0.0014
file:/Users/mostafa/Projects/forget/data/experiment3/kazakhstan,1,0.0014
file:/Users/mostafa/Projects/forget/data/experiment3/nucleated-red-blood-cells-present,1,0.0014
file:/Users/mostafa/Projects/forget/data/experiment3/cranial-neuralgia,1,0.0014
file:/Users/mostafa/Projects/forget/data/experiment3/jnk-inhibitor,1,0.0014
file:/Users/mostafa/Projects/forget/data/experiment3/oxaliplatin,1,0.0014
file:/Users/mostafa/Projects/forget/data/experiment3/oxazepam,1,0.0014
file:/Users/mostafa/Projects/forget/data/experiment3/depigmentation-drug,1,0.0014
file:/Users/mostafa/Projects/forget/data/experiment3/protective-agent,1,0.0014
file:/Users/mostafa/Projects/forget/data/experiment3/piriformis-muscle-syndrome,1,0.0014
file:/Users/mostafa/Projects/forget/data/experiment3/hepatitis-necrotising,1,0.0014
file:/Users/mostafa/Projects/forget/data/experiment3/fenofibrate,1,0.0014
file:/Users/mostafa/Projects/forget/data/experiment3/drug-export,1,0.0014
file:/Users/mostafa/Projects/forget/data/experiment3/raf-proto-oncogene-serinethreonine-protein-kinase,1,0.0014
file:/Users/mostafa/Projects/forget/data/experiment3/splenomegaly,1,0.0014
file:/Users/mostafa/Projects/forget/data/experiment3/dependence-producing-drug,1,0.0014
file:/Users/mostafa/Projects/forget/data/experiment3/estrogenic-steroids-alkylated,1,0.0014
file:/Users/mostafa/Projects/forget/data/experiment3/bacterial-disease,1,0.0014
file:/Users/mostafa/Projects/forget/data/experiment3/scopolamine-methobromide,1,0.0014
file:/Users/mostafa/Projects/forget/data/experiment3/plant-preparations,1,0.0014
file:/Users/mostafa/Projects/forget/data/experiment3/metformin,1,0.0014
file:/Users/mostafa/Projects/forget/data/experiment3/albuterol-ipratropium-drug-combination,1,0.0014
file:/Users/mostafa/Projects/forget/data/experiment3/turkey,1,0.0014
file:/Users/mostafa/Projects/forget/data/experiment3/hepatosplenitis,1,0.0014
file:/Users/mostafa/Projects/forget/data/experiment3/cyclophosphamide,1,0.0014
file:/Users/mostafa/Projects/forget/data/experiment3/weight-loss,1,0.0014
file:/Users/mostafa/Projects/forget/data/experiment3/peptide-drugs,1,0.0014
file:/Users/mostafa/Projects/forget/data/experiment3/co-administered-drug,1,0.0014
file:/Users/mostafa/Projects/forget/data/experiment3/application--use-,1,0.0014
file:/Users/mostafa/Projects/forget/data/experiment3/hyperchromatic-megakaryocyte,1,0.0014
file:/Users/mostafa/Projects/forget/data/experiment3/sodium-channel-blockers,1,0.0014
file:/Users/mostafa/Projects/forget/data/experiment3/stomatitis,1,0.0014
file:/Users/mostafa/Projects/forget/data/experiment3/paroxetine-maleate,1,0.0014
file:/Users/mostafa/Projects/forget/data/experiment3/demulcents,1,0.0014
file:/Users/mostafa/Projects/forget/data/experiment3/blood-count-depression,1,0.0014
file:/Users/mostafa/Projects/forget/data/experiment3/vincristine,1,0.0014
file:/Users/mostafa/Projects/forget/data/experiment3/substance-related-to-drugs,2,0.0027
file:/Users/mostafa/Projects/forget/data/experiment3/artesunate,1,0.0014
file:/Users/mostafa/Projects/forget/data/experiment3/blood,1,0.0014
file:/Users/mostafa/Projects/forget/data/experiment3/seed-compound,1,0.0014
file:/Users/mostafa/Projects/forget/data/experiment3/dopamine,1,0.0014
file:/Users/mostafa/Projects/forget/data/experiment3/abnormality-of-the-liver,1,0.0014
file:/Users/mostafa/Projects/forget/data/experiment3/phosphatidylethanolamine-binding-protein,1,0.0014
file:/Users/mostafa/Projects/forget/data/experiment3/korea-republic-of,1,0.0014
file:/Users/mostafa/Projects/forget/data/experiment3/oxycodone-controlled-release-tablet,1,0.0014
file:/Users/mostafa/Projects/forget/data/experiment3/sglt2-inhibitor,1,0.0014
file:/Users/mostafa/Projects/forget/data/experiment3/5-azacytidine,1,0.0014
file:/Users/mostafa/Projects/forget/data/experiment3/rho-kinase-inhibitor,1,0.0014
file:/Users/mostafa/Projects/forget/data/experiment3/philippines,1,0.0014
file:/Users/mostafa/Projects/forget/data/experiment3/selenomonas-sputigena,1,0.0014
file:/Users/mostafa/Projects/forget/data/experiment3/urologic-active-drug,1,0.0014
file:/Users/mostafa/Projects/forget/data/experiment3/decreased-resistance-to,2,0.0027
file:/Users/mostafa/Projects/forget/data/experiment3/prochlorperazine,1,0.0014
file:/Users/mostafa/Projects/forget/data/experiment3/drug-for-genitalia,1,0.0014
file:/Users/mostafa/Projects/forget/data/experiment3/cholanes,5,0.0068
file:/Users/mostafa/Projects/forget/data/experiment3/sulmazole,1,0.0014
file:/Users/mostafa/Projects/forget/data/experiment3/blood-coagulation-factor-inhibitors,1,0.0014
file:/Users/mostafa/Projects/forget/data/experiment3/vascular-system,1,0.0014
file:/Users/mostafa/Projects/forget/data/experiment3/voltage-gated-sodium-channel-agonists,1,0.0014
file:/Users/mostafa/Projects/forget/data/experiment3/antagonist,1,0.0014
file:/Users/mostafa/Projects/forget/data/experiment3/radiation-hepatitis,1,0.0014
file:/Users/mostafa/Projects/forget/data/experiment3/sunitinib,2,0.0027
file:/Users/mostafa/Projects/forget/data/experiment3/nostrums,1,0.0014
file:/Users/mostafa/Projects/forget/data/experiment3/diuretic,1,0.0014
file:/Users/mostafa/Projects/forget/data/experiment3/hepatitis-allergic-drug-induced,1,0.0014
file:/Users/mostafa/Projects/forget/data/experiment3/drug-acting-on-blood-and-body-fluid,1,0.0014
file:/Users/mostafa/Projects/forget/data/experiment3/breast-cancer-diagnosis-Concept,2,0.0027
file:/Users/mostafa/Projects/forget/data/experiment3/alzheimers-disease,2,0.0027
file:/Users/mostafa/Projects/forget/data/experiment3/nephrotic-syndrome,3,0.0041
file:/Users/mostafa/Projects/forget/data/experiment3/adjuvant-analgesics,1,0.0014
file:/Users/mostafa/Projects/forget/data/experiment3/benomyl,1,0.0014
file:/Users/mostafa/Projects/forget/data/experiment3/lacrimator,1,0.0014
file:/Users/mostafa/Projects/forget/data/experiment3/hormone,2,0.0027
file:/Users/mostafa/Projects/forget/data/experiment3/role--knapsack-,1,0.0014
file:/Users/mostafa/Projects/forget/data/experiment3/indomethacin,1,0.0014
file:/Users/mostafa/Projects/forget/data/experiment3/trifluoperazine,1,0.0014
file:/Users/mostafa/Projects/forget/data/experiment3/china,1,0.0014
file:/Users/mostafa/Projects/forget/data/experiment3/enterokinesis-improving-drug,1,0.0014
file:/Users/mostafa/Projects/forget/data/experiment3/organ-extract-pharmaceutical,1,0.0014
file:/Users/mostafa/Projects/forget/data/experiment3/antirheumatic-drug,1,0.0014
file:/Users/mostafa/Projects/forget/data/experiment3/drug-role,1,0.0014
file:/Users/mostafa/Projects/forget/data/experiment3/cyclosporin-a,1,0.0014
file:/Users/mostafa/Projects/forget/data/experiment3/pain,1,0.0014
file:/Users/mostafa/Projects/forget/data/experiment3/orexin-receptor-antagonists,1,0.0014
file:/Users/mostafa/Projects/forget/data/experiment3/metoprolol,1,0.0014
file:/Users/mostafa/Projects/forget/data/experiment3/sitagliptin-phosphate-metformin-hydrochloride-drug-combination,1,0.0014
file:/Users/mostafa/Projects/forget/data/experiment3/increased-resistance-to,2,0.0027
file:/Users/mostafa/Projects/forget/data/experiment3/candesartan,1,0.0014
file:/Users/mostafa/Projects/forget/data/experiment3/antimicrobial-drug,1,0.0014
file:/Users/mostafa/Projects/forget/data/experiment3/lapatinib,1,0.0014
file:/Users/mostafa/Projects/forget/data/experiment3/fenazaquin,1,0.0014
file:/Users/mostafa/Projects/forget/data/experiment3/purinergic-p2y-receptor-antagonists,1,0.0014
file:/Users/mostafa/Projects/forget/data/experiment3/drug-induced-hepatitis,1,0.0014
file:/Users/mostafa/Projects/forget/data/experiment3/fenpropimorph,1,0.0014
file:/Users/mostafa/Projects/forget/data/experiment3/hong-kong,1,0.0014
file:/Users/mostafa/Projects/forget/data/experiment3/calcium-receptor-agonist,1,0.0014
file:/Users/mostafa/Projects/forget/data/experiment3/hypercellular-bone-marrow,2,0.0027
file:/Users/mostafa/Projects/forget/data/experiment3/recombinant-drug,1,0.0014
file:/Users/mostafa/Projects/forget/data/experiment3/brimonidine-tartrate-timolol-maleate-drug-combination,1,0.0014
file:/Users/mostafa/Projects/forget/data/experiment3/propofol,1,0.0014
file:/Users/mostafa/Projects/forget/data/experiment3/fludarabine-phosphate,1,0.0014
file:/Users/mostafa/Projects/forget/data/experiment3/lung-disease,2,0.0027
file:/Users/mostafa/Projects/forget/data/experiment3/leukocyte,1,0.0014
file:/Users/mostafa/Projects/forget/data/experiment3/cetraxates,1,0.0014
file:/Users/mostafa/Projects/forget/data/experiment3/abacavir,1,0.0014
file:/Users/mostafa/Projects/forget/data/experiment3/radiosensitizer,1,0.0014
file:/Users/mostafa/Projects/forget/data/experiment3/anti-inflammatory-drug,1,0.0014
file:/Users/mostafa/Projects/forget/data/experiment3/pharmacological-action,2,0.0027
file:/Users/mostafa/Projects/forget/data/experiment3/unapprovedunpermitted-drugs,1,0.0014
file:/Users/mostafa/Projects/forget/data/experiment3/noma,16,0.0217
file:/Users/mostafa/Projects/forget/data/experiment3/halothane,1,0.0014
file:/Users/mostafa/Projects/forget/data/experiment3/map-kinase-inhibitor,1,0.0014
file:/Users/mostafa/Projects/forget/data/experiment3/cell-preparation,1,0.0014
file:/Users/mostafa/Projects/forget/data/experiment3/acenocoumarol,1,0.0014
file:/Users/mostafa/Projects/forget/data/experiment3/nootropic-agent,1,0.0014
file:/Users/mostafa/Projects/forget/data/experiment3/drugs-investigational,1,0.0014
file:/Users/mostafa/Projects/forget/data/experiment3/myelodysplastic-syndrome-with-isolated-del-5q-,1,0.0014
file:/Users/mostafa/Projects/forget/data/experiment3/histaminergic-agonist,1,0.0014
file:/Users/mostafa/Projects/forget/data/experiment3/anaesthetic,1,0.0014
file:/Users/mostafa/Projects/forget/data/experiment3/giant-cell-hepatitis,1,0.0014
file:/Users/mostafa/Projects/forget/data/experiment3/hepatitis-Concept,1,0.0014
file:/Users/mostafa/Projects/forget/data/experiment3/goitrogen,1,0.0014
file:/Users/mostafa/Projects/forget/data/experiment3/marked-bone-marrow-fibrosis,1,0.0014
file:/Users/mostafa/Projects/forget/data/experiment3/drugs-essential,1,0.0014
file:/Users/mostafa/Projects/forget/data/experiment3/adenocarcinoma,1,0.0014
file:/Users/mostafa/Projects/forget/data/experiment3/acyclovir,1,0.0014
file:/Users/mostafa/Projects/forget/data/experiment3/cinnamaldehyde,1,0.0014
file:/Users/mostafa/Projects/forget/data/experiment3/camptothecin,1,0.0014
file:/Users/mostafa/Projects/forget/data/experiment3/d-mannitol,1,0.0014
file:/Users/mostafa/Projects/forget/data/experiment3/efavirenz-emtricitabine-tenofovir-disoproxil-fumarate-drug-combination,1,0.0014
file:/Users/mostafa/Projects/forget/data/experiment3/product,1,0.0014
file:/Users/mostafa/Projects/forget/data/experiment3/hepatitis,61,0.0828
file:/Users/mostafa/Projects/forget/data/experiment3/tear-drop-red-blood-cell,1,0.0014
file:/Users/mostafa/Projects/forget/data/experiment3/tajikistan,1,0.0014
file:/Users/mostafa/Projects/forget/data/experiment3/agranulocytosis,1,0.0014
file:/Users/mostafa/Projects/forget/data/experiment3/pharmacological-role,1,0.0014
file:/Users/mostafa/Projects/forget/data/experiment3/orphan-drug,1,0.0014
file:/Users/mostafa/Projects/forget/data/experiment3/fitz-hugh-curtis-syndrome,1,0.0014
file:/Users/mostafa/Projects/forget/data/experiment3/fatigue,1,0.0014
file:/Users/mostafa/Projects/forget/data/experiment3/mek-inhibitor,1,0.0014
file:/Users/mostafa/Projects/forget/data/experiment3/4-hydroxyphenyl-retinamide,1,0.0014
file:/Users/mostafa/Projects/forget/data/experiment3/laxative,1,0.0014
file:/Users/mostafa/Projects/forget/data/experiment3/medical-plant,1,0.0014
file:/Users/mostafa/Projects/forget/data/experiment3/antiperspirant,3,0.0041
file:/Users/mostafa/Projects/forget/data/experiment3/sodium-channel-agonists,1,0.0014
file:/Users/mostafa/Projects/forget/data/experiment3/antidote,1,0.0014
file:/Users/mostafa/Projects/forget/data/experiment3/amlodipine-valsartan-drug-combination,1,0.0014
file:/Users/mostafa/Projects/forget/data/experiment3/nitrogen-heterocyclic-compound,1,0.0014
file:/Users/mostafa/Projects/forget/data/experiment3/selenomonas-noxia,1,0.0014
file:/Users/mostafa/Projects/forget/data/experiment3/rofecoxib,1,0.0014
file:/Users/mostafa/Projects/forget/data/experiment3/macau,1,0.0014
file:/Users/mostafa/Projects/forget/data/experiment3/hypocellular-bone-marrow,1,0.0014
file:/Users/mostafa/Projects/forget/data/experiment3/enbrel,1,0.0014
file:/Users/mostafa/Projects/forget/data/experiment3/diethylstilbestrol,1,0.0014
file:/Users/mostafa/Projects/forget/data/experiment3/non-alcoholic-steatohepatitis,1,0.0014
file:/Users/mostafa/Projects/forget/data/experiment3/antiprogestin,1,0.0014
file:/Users/mostafa/Projects/forget/data/experiment3/warfarin,1,0.0014
file:/Users/mostafa/Projects/forget/data/experiment3/transformed-peripheral-b-lymphocyte,1,0.0014
file:/Users/mostafa/Projects/forget/data/experiment3/raloxifene,1,0.0014
file:/Users/mostafa/Projects/forget/data/experiment3/salmeterol,1,0.0014
file:/Users/mostafa/Projects/forget/data/experiment3/diagnosis,1,0.0014
file:/Users/mostafa/Projects/forget/data/experiment3/smoking-cessation-drug,1,0.0014
file:/Users/mostafa/Projects/forget/data/experiment3/norfloxacin,1,0.0014
file:/Users/mostafa/Projects/forget/data/experiment3/hla-dq-antigens,1,0.0014
file:/Users/mostafa/Projects/forget/data/experiment3/drug,488,0.6621
file:/Users/mostafa/Projects/forget/data/experiment3/minor-element-formulation,1,0.0014
file:/Users/mostafa/Projects/forget/data/experiment3/first-line-drug,1,0.0014
file:/Users/mostafa/Projects/forget/data/experiment3/photosensitizing-agent,1,0.0014
file:/Users/mostafa/Projects/forget/data/experiment3/tacrine,1,0.0014
file:/Users/mostafa/Projects/forget/data/experiment3/bromocriptine-methanesulfonate,1,0.0014
file:/Users/mostafa/Projects/forget/data/experiment3/bradykinin-antagonist,1,0.0014
file:/Users/mostafa/Projects/forget/data/experiment3/megakaryocytes-increased-in-bone-marrow,1,0.0014
file:/Users/mostafa/Projects/forget/data/experiment3/folk-medicine,1,0.0014
file:/Users/mostafa/Projects/forget/data/experiment3/steatohepatitis,1,0.0014
file:/Users/mostafa/Projects/forget/data/experiment3/-2z3z--bisamino-2-aminophenyl-sulfanylmethylidenebutanedinitrile,1,0.0014
file:/Users/mostafa/Projects/forget/data/experiment3/angiogenesis-modulating-agent,1,0.0014
file:/Users/mostafa/Projects/forget/data/experiment3/neuralgia,16,0.0217
file:/Users/mostafa/Projects/forget/data/experiment3/motexafin-gadolinium,1,0.0014
file:/Users/mostafa/Projects/forget/data/experiment3/verapamil,1,0.0014
file:/Users/mostafa/Projects/forget/data/experiment3/high-risk-drug,1,0.0014
file:/Users/mostafa/Projects/forget/data/experiment3/inflammatory-disorder-of-digestive-system,1,0.0014
file:/Users/mostafa/Projects/forget/data/experiment3/amisulpride,1,0.0014
file:/Users/mostafa/Projects/forget/data/experiment3/uzbekistan,1,0.0014
file:/Users/mostafa/Projects/forget/data/experiment3/olanzapine,1,0.0014
file:/Users/mostafa/Projects/forget/data/experiment3/bronchoconstrictor-agent,1,0.0014
file:/Users/mostafa/Projects/forget/data/experiment3/diffuse-large-b-cell-lymphoma,1,0.0014
file:/Users/mostafa/Projects/forget/data/experiment3/doxycycline,1,0.0014
file:/Users/mostafa/Projects/forget/data/experiment3/psychiatry,1,0.0014
file:/Users/mostafa/Projects/forget/data/experiment3/japan,1,0.0014
file:/Users/mostafa/Projects/forget/data/experiment3/cholangiohepatitis,1,0.0014
file:/Users/mostafa/Projects/forget/data/experiment3/ulcerative-stomatitis,1,0.0014
file:/Users/mostafa/Projects/forget/data/experiment3/carcinoid-heart-disease,9,0.0122
file:/Users/mostafa/Projects/forget/data/experiment3/hypolobated-megakaryocyte,1,0.0014
file:/Users/mostafa/Projects/forget/data/experiment3/nemonapride,1,0.0014
file:/Users/mostafa/Projects/forget/data/experiment3/vascular-disrupting-agents,1,0.0014
file:/Users/mostafa/Projects/forget/data/experiment3/fluoroquinolones,1,0.0014
file:/Users/mostafa/Projects/forget/data/experiment3/cholic-acids,1,0.0014
file:/Users/mostafa/Projects/forget/data/experiment3/atorvastatin,1,0.0014
file:/Users/mostafa/Projects/forget/data/experiment3/ajoene,2,0.0027
file:/Users/mostafa/Projects/forget/data/experiment3/vitamin,3,0.0041
file:/Users/mostafa/Projects/forget/data/experiment3/clonal-t-cell-receptor-gene-rearrangement,1,0.0014
file:/Users/mostafa/Projects/forget/data/experiment3/ticlopidine,1,0.0014
file:/Users/mostafa/Projects/forget/data/experiment3/state-of-palestine,1,0.0014
file:/Users/mostafa/Projects/forget/data/experiment3/-s------sulpiride,1,0.0014
file:/Users/mostafa/Projects/forget/data/experiment3/immuno-enhancing-diet,1,0.0014
file:/Users/mostafa/Projects/forget/data/experiment3/azathioprine,1,0.0014
file:/Users/mostafa/Projects/forget/data/experiment3/dasatinib,1,0.0014
file:/Users/mostafa/Projects/forget/data/experiment3/antiallergic-agent,1,0.0014
file:/Users/mostafa/Projects/forget/data/experiment3/metamizole,1,0.0014
file:/Users/mostafa/Projects/forget/data/experiment3/antidyskinesia-agent,1,0.0014
file:/Users/mostafa/Projects/forget/data/experiment3/adenosine-antagonist,1,0.0014
file:/Users/mostafa/Projects/forget/data/experiment3/prodrug,1,0.0014
file:/Users/mostafa/Projects/forget/data/experiment3/muscle-relaxation-antagonist,1,0.0014
file:/Users/mostafa/Projects/forget/data/experiment3/nasal-decongestant,1,0.0014
file:/Users/mostafa/Projects/forget/data/experiment3/estrogen-receptor-modulators,1,0.0014
file:/Users/mostafa/Projects/forget/data/experiment3/cambodia,1,0.0014
file:/Users/mostafa/Projects/forget/data/experiment3/diazepam,1,0.0014
file:/Users/mostafa/Projects/forget/data/experiment3/large-atypical-platelet,1,0.0014
file:/Users/mostafa/Projects/forget/data/experiment3/poikilocytosis,1,0.0014
file:/Users/mostafa/Projects/forget/data/experiment3/oral-mucosal-injury-preparations,1,0.0014
file:/Users/mostafa/Projects/forget/data/experiment3/anorexia-nervosa,2,0.0027
file:/Users/mostafa/Projects/forget/data/experiment3/melatonin-receptor-agonist,1,0.0014
file:/Users/mostafa/Projects/forget/data/experiment3/bicalutamide,1,0.0014
file:/Users/mostafa/Projects/forget/data/experiment3/dyspnea,1,0.0014
file:/Users/mostafa/Projects/forget/data/experiment3/alcoholic-hepatitis,1,0.0014
file:/Users/mostafa/Projects/forget/data/experiment3/geographic-locations,1,0.0014
file:/Users/mostafa/Projects/forget/data/experiment3/hepatitis-non-icteric,1,0.0014
file:/Users/mostafa/Projects/forget/data/experiment3/appetite-regulator,1,0.0014
file:/Users/mostafa/Projects/forget/data/experiment3/n-acetyl-l-cysteine,1,0.0014
file:/Users/mostafa/Projects/forget/data/experiment3/celecoxib,1,0.0014
file:/Users/mostafa/Projects/forget/data/experiment3/peripheral-neuropathy,1,0.0014
file:/Users/mostafa/Projects/forget/data/experiment3/metabolic-drug,1,0.0014
file:/Users/mostafa/Projects/forget/data/experiment3/bangladesh,1,0.0014
file:/Users/mostafa/Projects/forget/data/experiment3/antitussive-agent,1,0.0014
file:/Users/mostafa/Projects/forget/data/experiment3/favorable-clinical-outcome,1,0.0014
file:/Users/mostafa/Projects/forget/data/experiment3/retired-concept-2010,1,0.0014
file:/Users/mostafa/Projects/forget/data/experiment3/chlorpropamide,1,0.0014
file:/Users/mostafa/Projects/forget/data/experiment3/interferon-inducer,1,0.0014
file:/Users/mostafa/Projects/forget/data/experiment3/admixture,1,0.0014
file:/Users/mostafa/Projects/forget/data/experiment3/granulocytopenia,1,0.0014
file:/Users/mostafa/Projects/forget/data/experiment3/oseltamivir,1,0.0014
file:/Users/mostafa/Projects/forget/data/experiment3/post-herpetic-neuralgia,1,0.0014
file:/Users/mostafa/Projects/forget/data/experiment3/potassium-voltage-gated-channel-subfamily-h-member-1,1,0.0014
file:/Users/mostafa/Projects/forget/data/experiment3/leukopenia-Concept,1,0.0014
file:/Users/mostafa/Projects/forget/data/experiment3/except-adaptation-use-drug,1,0.0014
file:/Users/mostafa/Projects/forget/data/experiment3/fibrin-modulating-drug,1,0.0014
file:/Users/mostafa/Projects/forget/data/experiment3/antiemetic,1,0.0014
file:/Users/mostafa/Projects/forget/data/experiment3/digestive-system-infectious-disease,1,0.0014
file:/Users/mostafa/Projects/forget/data/experiment3/growth-stimulant,1,0.0014
file:/Users/mostafa/Projects/forget/data/experiment3/drugs-and-toxic-substances,1,0.0014
file:/Users/mostafa/Projects/forget/data/experiment3/purinergic-p1-receptor-agonists,1,0.0014
file:/Users/mostafa/Projects/forget/data/experiment3/zardaverine,1,0.0014
file:/Users/mostafa/Projects/forget/data/experiment3/httpsbmi,1,0.0014
file:/Users/mostafa/Projects/forget/data/experiment3/primary-myelofibrosis,1,0.0014
file:/Users/mostafa/Projects/forget/data/experiment3/voltage-gated-sodium-channel-blockers,1,0.0014
file:/Users/mostafa/Projects/forget/data/experiment3/endothelin-1,1,0.0014
file:/Users/mostafa/Projects/forget/data/experiment3/purinergic-agonist,1,0.0014
file:/Users/mostafa/Projects/forget/data/experiment3/purinergic-p2-receptor-antagonists,1,0.0014
file:/Users/mostafa/Projects/forget/data/experiment3/dermatologic-preparation,1,0.0014
file:/Users/mostafa/Projects/forget/data/experiment3/brunei-darussalam,1,0.0014
file:/Users/mostafa/Projects/forget/data/experiment3/pancytopenia,2,0.0027
file:/Users/mostafa/Projects/forget/data/experiment3/antihyperkalemic-agents,1,0.0014
file:/Users/mostafa/Projects/forget/data/experiment3/bacterium,1,0.0014
file:/Users/mostafa/Projects/forget/data/experiment3/low-grade-fever,1,0.0014
file:/Users/mostafa/Projects/forget/data/experiment3/taiwan,1,0.0014
file:/Users/mostafa/Projects/forget/data/experiment3/crh-gene,1,0.0014
file:/Users/mostafa/Projects/forget/data/experiment3/----demecolcine,1,0.0014
file:/Users/mostafa/Projects/forget/data/experiment3/anemia,1,0.0014
file:/Users/mostafa/Projects/forget/data/experiment3/enzyme-preparation,3,0.0041
file:/Users/mostafa/Projects/forget/data/experiment3/halothane-hepatitis,1,0.0014
file:/Users/mostafa/Projects/forget/data/experiment3/hypoglycemic-agent,1,0.0014
file:/Users/mostafa/Projects/forget/data/experiment3/anticonvulsant,1,0.0014
file:/Users/mostafa/Projects/forget/data/experiment3/nandrolone,1,0.0014
file:/Users/mostafa/Projects/forget/data/experiment3/calcimimetic,1,0.0014
file:/Users/mostafa/Projects/forget/data/experiment3/steroids,1,0.0014
file:/Users/mostafa/Projects/forget/data/experiment3/all-cis-docosa-4710131619-hexaenoic-acid,1,0.0014
file:/Users/mostafa/Projects/forget/data/experiment3/citalopram,1,0.0014
file:/Users/mostafa/Projects/forget/data/experiment3/cytopenia,1,0.0014
